Author(s):
Geetanjali Shinde, Akash Thombre, Mayuri Bhadalekar, Nilesh Chougule, Bhavana Shelke, Shalini Shinde
Email(s):
aditishinde8390@gmail.com , geetanjalishinde1562@gmail.com , mr.akashthombre@gmail.com
DOI:
10.52711/2231-5691.2025.00016 
Address:
Geetanjali Shinde1*, Akash Thombre2, Mayuri Bhadalekar3, Nilesh Chougule4,Bhavana Shelke5, Shalini Shinde6
1Student, Ashokrao Mane Institute of Pharmacy, Ambap - 416112, Kolhapur, Maharashtra, India.
2Assistant Professor, Ashokrao Mane Institute of Pharmacy, Ambap - 416112, Kolhapur, Maharashtra, India.
3Assistant Professor, Ashokrao Mane Institute of Pharmacy, Ambap - 416112, Kolhapur, Maharashtra, India.
4Principal, Ashokrao Mane Institute of Pharmacy, Ambap - 416112, Kolhapur, Maharashtra, India.
5Student, Ashokrao Mane Institute of Pharmacy, Ambap - 416112, Kolhapur, Maharashtra, India.
6Assistant Professor, Womens College of Pharmacy, Peth – Vadgaon - 416112, Kolhapur, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
Cancer of the breast develops when abnormal cells in breast multiply and spread out of control, prominent to formation of a tumour. The cells that line the milk ducts of the breast are the usual starting point for breast cancer. Breast tumors, alterations in breast nature or size, dimpling skin, inability to milk, discharge from the nipple, nipple inversion, or reddening or scaling of the skin are all possible signs of breast cancer.Molecular docking has emerged as a powerful computational tool in the field of breast cancer research, facilitating the exploration of interactions between small molecules and target proteins implicated in disease pathways.After retrieving the protein from Protein Data Bank, Biovia Discovery Studio was used to generate its crystal structure. Advances in computational algorithms and structural biology techniques have enhanced the accuracy and applicability of docking simulations, allowing researchers to screen large compound libraries efficiently and prioritize lead compounds for further experimental validation. After obtaining the phytochemicals from the NCBI PubChem database, their molecular structures were generated using Open Babel. PyRx was used to perform molecular docking using Autodock Vina. The web servers pkCSM and SwissADME were utilized to calculate the ADMET properties of the top-performing compounds. This abstract summarizes the role of molecular docking in breast cancer research, emphasizing its utility in drug discovery, interaction prediction, and therapeutic development.
Cite this article:
Geetanjali Shinde, Akash Thombre, Mayuri Bhadalekar, Nilesh Chougule,Bhavana Shelke, Shalini Shinde. Molecular Docking, Drug likeness Studies and ADMET Prediction of Phytochemical of plant Ipomoea Tricolor for Breast Cancer Activity. Asian Journal of Pharmaceutical Research. 2025; 15(2):97-3. doi: 10.52711/2231-5691.2025.00016
Cite(Electronic):
Geetanjali Shinde, Akash Thombre, Mayuri Bhadalekar, Nilesh Chougule,Bhavana Shelke, Shalini Shinde. Molecular Docking, Drug likeness Studies and ADMET Prediction of Phytochemical of plant Ipomoea Tricolor for Breast Cancer Activity. Asian Journal of Pharmaceutical Research. 2025; 15(2):97-3. doi: 10.52711/2231-5691.2025.00016 Available on: https://asianjpr.com/AbstractView.aspx?PID=2025-15-2-1
REFERENCE:
1. Genetics of breast cancer: a topic in evolution. Shiovitz S, Korde LA. Ann Oncol. 2015; 26:1291–1299.
2. Breast Cancer Risk Factors You Can’t Change. [ Jun; 2023]. 2023.
3. Alkabban FM, Ferguson T. Treasure Island, FL: Stat Pearls Publishing; 2023. Breast Cancer.
4. Centers for Disease Control and Prevention. Basic Information About Breast Cancer. [ Jun; 2023]. 2022.
5. Invasive Ductal Carcinoma (IDC): Grade, Symptoms and Diagnosis. [ Jun; 2023]. 2023.
6. Lundqvist A., Andersson E., Ahlberg I., Nilbert M., Gerdtham U. Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis. Eur. J. Public Health. 2016; 26: 804–813. Doi: 10.1093/eurpub/ckw070.
7. Azamjah N., Soltan-Zadeh Y., Zayeri F. Global trend of breast cancer mortality rate: A 25-year study. Asian Pac. J. Cancer Prev. 2019; 20: 2015–2020. Doi:10.31557/APJCP.2019.20.7.2015.
8. Breasted JH, editor. The Edwin Smith Surgical papyrus. Chicago, Illinois: The University Chicago Press; 1930. Special edition, 1984.
9. Homer. Iliad. [Translated by WHD Rouse] New York: A Signet Classic. New American Library; 1966. P. 36.
10. Breast cancer. [ Jun; 2023]. 2023.
11. Lyons AS, Petrucelli RJ. Medicine – An illustrated history. New York: Harry N. Abrams Publishers; 1978. Pp. 294–317.
12. Heer E., Harper A., Escandor N., Sung H., McCormack V., Fidler-Benaoudia M.M. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Global Health. 2020; 8(8): e1027– e1037.
13. Anderson B.O., Ilbawi A.M., Fidarova E., Weiderpass E., Stevens L., Abdel-Wahab M., Mikkelsen B. The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases. Lancet Oncol.2021; 22(5): 578–581.
14. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021; 71:209–249.
15. Ferlay J., Colombet M., Soerjomataram I., Parkin D.M., Piñeros M., Znaor A., et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021; 149:778–789.
16. Global Cancer Observatory: Cancer Today.Khakbazan Z., Taghipour A., Roudsari R.L., Mohammadi E. Help seeking behavior of women with self-discovered breast cancer symptoms: a meta ethnographic synthesis of patient delay. PLoS One. 2014; 9:1–24.
17. Khakbazan Z., Taghipour A., Roudsari R.L., Mohammadi E. Help seeking behavior of women with self-discovered breast cancer symptoms: a meta ethnographic synthesis of patient delay. PLoS One. 2014; 9:1–24.
18. O’Mahony M., McCarthy G., Corcoran P., Hegarty J. Shedding light on women’s help seeking behavior for self-discovered breast symptoms. Eur. J. Oncol. Nurs. 2013; 17:632–639.
19. Current breast cancer risks of hormone replacement therapy in postmenopausal women. Shah NR, Wong T. Expert OpinPharmacother. 2006; 7:2455–2463.
20. Cable JK, Grider MH. Treasure Island, FL: StatPearls Publishing; 2023. Physiology, ProgesteroneEndocrine disruptors from the environment affecting breast cancer. Calaf GM, Ponce-Cusi R, Aguayo F, Mun oz JP, Bleak TC. Oncol Lett. 2020; 20:19–32.
21. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Cheng CH, Chen LR, Chen KH. Int J Mol Sci. 2022; 23:1376.
22. Endocrine disruptors from the environment affecting breast cancer. Calaf GM, Ponce-Cusi R, Aguayo F, Mun oz JP, Bleak TC. Oncol Lett. 2020; 20:19–32.
23. The role of progesterone receptors in breast cancer. Li Z, Wei H, Li S, Wu P, MaoX. Drug Des Devel Ther. 2022; 16:305–314.
24. Hormone receptor loss in breast cancer: molecular mechanisms, clinical settings, and therapeutic implications. Zattarin E, Leporati R, Ligorio F, Lobefaro R, Vingiani A, Pruneri G, Vernieri C. Cells. 2020; 9:2644.
25. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Dunnwald LK, Rossing MA, Li CI. Breast Cancer Res. 2007; 9:0.
26. Targeted therapies in breast cancer: new challenges to fight against resistance. Masoud V, Page s G. World J Clin Oncol. 2017; 8:120–134.
27. Use of hormone replacement therapy and risk of breast cancer: nested casecontrol studies using the QResearch and CPRD databases. Vinogradova Y, Coupland C, Hippisley-Cox J. BMJ. 2020; 371:0.
28. Bonofiglio D., Giordano C., De Amicis F., Lanzino M., Ando S. Natural products as promising anti-tumoral agents in breast cancer: Mechanisms of action and molecular targets. Mini Rev. Med. Chem. 2016; 16:596–604. Doi:10.2174/1389557515666150709110959.